Chemours
487 hedge funds and large institutions have $3.12B invested in Chemours in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 137 increasing their positions, 172 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less capital invested
Capital invested by funds: $4.92B → $3.12B (-$1.8B)
40% less call options, than puts
Call options by funds: $65.8M | Put options by funds: $109M
44% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 101
Holders
487
Holding in Top 10
7
Calls
$65.8M
Puts
$109M
Top Buyers
| 1 | +$89.3M | |
| 2 | +$57M | |
| 3 | +$53.3M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$48M |
| 5 |
Goldman Sachs
New York
|
+$41.7M |
Top Sellers
| 1 | -$287M | |
| 2 | -$69.7M | |
| 3 | -$60.7M | |
| 4 |
GAM
Gotham Asset Management
New York
|
-$49.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.6M |